{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:10:51Z","timestamp":1794503451104,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2425013, 32470692, 32370701, 32170657"],"award-info":[{"award-number":["T2425013, 32470692, 32370701, 32170657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77187-8","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:53:34Z","timestamp":1787997214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct multi-omics signatures of clinical subgroups of type 2 diabetes define heterogeneous responses to an insulin sensitizer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-3104","authenticated-orcid":false,"given":"Zehui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-417X","authenticated-orcid":false,"given":"Naixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-7574","authenticated-orcid":false,"given":"Qiaochu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-5801","authenticated-orcid":false,"given":"Qingwang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-2168","authenticated-orcid":false,"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-2168","authenticated-orcid":false,"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-9577","authenticated-orcid":false,"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-4150","authenticated-orcid":false,"given":"Leming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-3147","authenticated-orcid":false,"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-8303","authenticated-orcid":false,"given":"Yuanting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"77187_CR1","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1038\/s41591-023-02502-5","volume":"29","author":"DK Tobias","year":"2023","unstructured":"Tobias, D. K. et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat. Med. 29, 2438\u20132457 (2023).","journal-title":"Nat. Med."},{"key":"77187_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","volume":"28","author":"ATN Nair","year":"2022","unstructured":"Nair, A. T. N. et al. Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat. Med. 28, 982\u2013988 (2022).","journal-title":"Nat. Med."},{"key":"77187_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"Ahmad, E., Lim, S., Lamptey, R., Webb, D. R. & Davies, M. J. Type 2 diabetes. Lancet 400, 1803\u20131820 (2022).","journal-title":"Lancet"},{"key":"77187_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361\u2013369 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","volume":"7","author":"X Zou","year":"2019","unstructured":"Zou, X., Zhou, X., Zhu, Z. & Ji, L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 7, 9\u201311 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR6","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","volume":"64","author":"RC Slieker","year":"2021","unstructured":"Slieker, R. C. et al. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia 64, 1982\u20131989 (2021).","journal-title":"Diabetologia"},{"key":"77187_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00125-021-05567-4","volume":"65","author":"M Pigeyre","year":"2022","unstructured":"Pigeyre, M. et al. Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial. Diabetologia 65, 206\u2013215 (2022).","journal-title":"Diabetologia"},{"key":"77187_CR8","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s00125-022-05741-2","volume":"65","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes. Diabetologia 65, 2146\u20132156 (2022).","journal-title":"Diabetologia"},{"key":"77187_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34754-z","volume":"13","author":"SB Zaghlool","year":"2022","unstructured":"Zaghlool, S. B. et al. Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population. Nat. Commun. 13, 7121 (2022).","journal-title":"Nat. Commun."},{"key":"77187_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","volume":"7","author":"OP Zaharia","year":"2019","unstructured":"Zaharia, O. P. et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 7, 684\u2013694 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G. & Hattersley, A. T. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 7, 442\u2013451 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR12","doi-asserted-by":"publisher","first-page":"155514","DOI":"10.1016\/j.metabol.2023.155514","volume":"141","author":"YC Hwang","year":"2023","unstructured":"Hwang, Y. C. et al. Subtypes of type 2 diabetes and their association with outcomes in Korean adults\u2014a cluster analysis of community-based prospective cohort. Metabolism 141, 155514 (2023).","journal-title":"Metabolism"},{"key":"77187_CR13","doi-asserted-by":"publisher","first-page":"102850","DOI":"10.1016\/j.dsx.2023.102850","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Data-driven subgroups of newly diagnosed type 2 diabetes and the relationship with cardiovascular diseases at genetic and clinical levels in Chinese adults. Diabetes Metab. Syndr. 17, 102850 (2023).","journal-title":"Diabetes Metab. Syndr."},{"key":"77187_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2337\/dc21-2489","volume":"45","author":"S Schrader","year":"2022","unstructured":"Schrader, S. et al. Novel subgroups of type 2 diabetes display different epigenetic patterns that associate with future diabetic complications. Diabetes Care 45, 1621\u20131630 (2022).","journal-title":"Diabetes Care"},{"key":"77187_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2213-8587(22)00005-5","volume":"10","author":"V Raverdy","year":"2022","unstructured":"Raverdy, V. et al. Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 10, 167\u2013176 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","volume":"569","author":"W Zhou","year":"2019","unstructured":"Zhou, W. et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature 569, 663\u2013671 (2019).","journal-title":"Nature"},{"key":"77187_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41587-022-01520-x","volume":"41","author":"RL Allesoe","year":"2023","unstructured":"Allesoe, R. L. et al. Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models. Nat. Biotechnol. 41, 399\u2013408 (2023).","journal-title":"Nat. Biotechnol."},{"key":"77187_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s43657-025-00266-1","volume":"5","author":"Z Cao","year":"2025","unstructured":"Cao, Z. et al. Baseline plasma GPX3 level predicts efficacy of insulin-sensitization drug chiglitazar in type 2 diabetes. Phenomics 5, 338\u2013342 (2025).","journal-title":"Phenomics"},{"key":"77187_CR19","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.2337\/db20-1281","volume":"70","author":"RC Slieker","year":"2021","unstructured":"Slieker, R. C. et al. Distinct molecular signatures of clinical clusters in people with type 2 diabetes: an IMI-RHAPSODY study. Diabetes 70, 2683\u20132693 (2021).","journal-title":"Diabetes"},{"key":"77187_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00125-023-05887-7","volume":"66","author":"M Pigeyre","year":"2023","unstructured":"Pigeyre, M., Gerstein, H., Ahlqvist, E., Hess, S. & Pare, G. Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial. Diabetologia 66, 1045\u20131051 (2023).","journal-title":"Diabetologia"},{"key":"77187_CR21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2337\/db20-1054","volume":"70","author":"C Herder","year":"2021","unstructured":"Herder, C. et al. Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70, 1198\u20131208 (2021).","journal-title":"Diabetes"},{"key":"77187_CR22","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.scib.2021.03.019","volume":"66","author":"L Ji","year":"2021","unstructured":"Ji, L. et al. Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP). Sci. Bull. 66, 1571\u20131580 (2021).","journal-title":"Sci. Bull."},{"key":"77187_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.scib.2021.02.027","volume":"66","author":"W Jia","year":"2021","unstructured":"Jia, W. et al. Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS). Sci. Bull. 66, 1581\u20131590 (2021).","journal-title":"Sci. Bull."},{"key":"77187_CR24","doi-asserted-by":"crossref","unstructured":"Sun, Y. et al. Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: a phase II, randomized, double-blind, placebo-controlled study. Hepatology 83, 1248\u20131260 (2026).","DOI":"10.1097\/HEP.0000000000001475"},{"key":"77187_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","volume":"582","author":"CN Spracklen","year":"2020","unstructured":"Spracklen, C. N. et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature 582, 240\u2013245 (2020).","journal-title":"Nature"},{"key":"77187_CR26","doi-asserted-by":"publisher","first-page":"e1002654","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler, M. S. et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med. 15, e1002654 (2018).","journal-title":"PLoS Med."},{"key":"77187_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","volume":"3","author":"JC Chambers","year":"2015","unstructured":"Chambers, J. C. et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 3, 526\u2013534 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"77187_CR28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41588-021-00948-2","volume":"53","author":"D Mansour Aly","year":"2021","unstructured":"Mansour Aly, D. et al. Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes. Nat. Genet. 53, 1534\u20131542 (2021).","journal-title":"Nat. Genet."},{"key":"77187_CR29","doi-asserted-by":"publisher","first-page":"D211","DOI":"10.1093\/nar\/gkab808","volume":"50","author":"A Keller","year":"2022","unstructured":"Keller, A. et al. miRNATissueAtlas2: an update to the human miRNA tissue atlas. Nucleic Acids Res. 50, D211\u2013D221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"77187_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ncb2286","volume":"13","author":"L Sun","year":"2011","unstructured":"Sun, L. et al. Mir193b-365 is essential for brown fat differentiation. Nat. Cell Biol. 13, 958\u2013965 (2011).","journal-title":"Nat. Cell Biol."},{"key":"77187_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/13813455.2021.1871762","volume":"129","author":"L Saeidi","year":"2023","unstructured":"Saeidi, L., Shahrokhi, S. Z., Sadatamini, M., Jafarzadeh, M. & Kazerouni, F. Can circulating miR-7-1-5p, and miR-33a-5p be used as markers of T2D patients?. Arch. Physiol. Biochem. 129, 771\u2013777 (2023).","journal-title":"Arch. Physiol. Biochem."},{"key":"77187_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbadis.2018.11.009","volume":"1865","author":"JE Nahon","year":"2019","unstructured":"Nahon, J. E. et al. Proteoglycan 4 deficiency protects against glucose intolerance and fatty liver disease in diet-induced obese mice. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 494\u2013501 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"77187_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v11.i1.1","volume":"11","author":"K Shim","year":"2020","unstructured":"Shim, K., Begum, R., Yang, C. & Wang, H. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus. World J. Diabetes 11, 1\u201312 (2020).","journal-title":"World J. Diabetes"},{"key":"77187_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41574-023-00900-w","volume":"19","author":"IL Kruglikov","year":"2023","unstructured":"Kruglikov, I. L. & Scherer, P. E. Control of adipose tissue cellularity by the terminal complement cascade. Nat. Rev. Endocrinol. 19, 679\u2013680 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"77187_CR35","doi-asserted-by":"crossref","unstructured":"Martinez Leon, V., Hilburg, R. & Susztak, K. Mechanisms of diabetic kidney disease and established and emerging treatments. Nat. Rev. Endocrinol. 22, 21\u201335 (2026).","DOI":"10.1038\/s41574-025-01171-3"},{"key":"77187_CR36","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet, I. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180, 862\u2013877 e822 (2020).","journal-title":"Cell"},{"key":"77187_CR37","doi-asserted-by":"crossref","unstructured":"Li, P.F. & Chen, W.L. Are the different diabetes subgroups correlated with all-cause, cancer-related, and cardiovascular-related mortality? J. Clin. Endocrinol. Metab. 105, dgaa628 (2020).","DOI":"10.1210\/clinem\/dgaa628"},{"key":"77187_CR38","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Validation of the Swedish diabetes re-grouping scheme in adult-onset diabetes in China. J. Clin. Endocrinol. Metab. 105, dgaa524 (2020).","DOI":"10.1210\/clinem\/dgaa524"},{"key":"77187_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00125-021-05543-y","volume":"65","author":"RB Prasad","year":"2022","unstructured":"Prasad, R. B. et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia 65, 65\u201378 (2022).","journal-title":"Diabetologia"},{"key":"77187_CR40","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","volume":"5","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol. Hepatol. 5, 970\u2013985 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"77187_CR41","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","volume":"64","author":"CJ Pirola","year":"2015","unstructured":"Pirola, C. J. et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut 64, 800\u2013812 (2015).","journal-title":"Gut"},{"key":"77187_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt, J. et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature 438, 685\u2013689 (2005).","journal-title":"Nature"},{"key":"77187_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau, C. et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87\u201398 (2006).","journal-title":"Cell Metab."},{"key":"77187_CR44","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.3748\/wjg.v23.i46.8140","volume":"23","author":"XL Liu","year":"2017","unstructured":"Liu, X. L. et al. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J. Gastroenterol. 23, 8140\u20138151 (2017).","journal-title":"World J. Gastroenterol."},{"key":"77187_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.31050","volume":"72","author":"XL Liu","year":"2020","unstructured":"Liu, X. L. et al. Lipotoxic hepatocyte-derived exosomal MicroRNA 192-5p activates macrophages through Rictor\/Akt\/Forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease. Hepatology 72, 454\u2013469 (2020).","journal-title":"Hepatology"},{"key":"77187_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41569-021-00613-5","volume":"19","author":"A Mehta","year":"2022","unstructured":"Mehta, A. & Shapiro, M. D. Apolipoproteins in vascular biology and atherosclerotic disease. Nat. Rev. Cardiol. 19, 168\u2013179 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"77187_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804\u2013810 (2011).","journal-title":"Cell Metab."},{"key":"77187_CR48","doi-asserted-by":"publisher","first-page":"104714","DOI":"10.1016\/j.ebiom.2023.104714","volume":"94","author":"B Dewidar","year":"2023","unstructured":"Dewidar, B. et al. Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases. EBioMedicine 94, 104714 (2023).","journal-title":"EBioMedicine"},{"key":"77187_CR49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448\u2013453 (2011).","journal-title":"Nat. Med."},{"key":"77187_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"77187_CR51","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","volume":"18","author":"M Masoodi","year":"2021","unstructured":"Masoodi, M. et al. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat. Rev. Gastroenterol. Hepatol. 18, 835\u2013856 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77187_CR52","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","volume":"67","author":"N Jiao","year":"2018","unstructured":"Jiao, N. et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut 67, 1881\u20131891 (2018).","journal-title":"Gut"},{"key":"77187_CR53","doi-asserted-by":"publisher","first-page":"21075","DOI":"10.1073\/pnas.1118922109","volume":"108","author":"RJ Frost","year":"2011","unstructured":"Frost, R. J. & Olson, E. N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl. Acad. Sci. USA 108, 21075\u201321080 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77187_CR54","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel, A. R. & Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799\u2013806 (2001).","journal-title":"Nature"},{"key":"77187_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12944-022-01623-z","volume":"21","author":"X Peng","year":"2022","unstructured":"Peng, X. et al. Roles of plasma leptin and resistin in novel subgroups of type 2 diabetes driven by cluster analysis. Lipids Health Dis. 21, 7 (2022).","journal-title":"Lipids Health Dis."},{"key":"77187_CR56","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41422-021-00564-z","volume":"31","author":"L Li","year":"2021","unstructured":"Li, L. et al. The ChinaMAP reference panel for the accurate genotype imputation in Chinese populations. Cell Res. 31, 1308\u20131310 (2021).","journal-title":"Cell Res."},{"key":"77187_CR57","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/bioinformatics\/btt730","volume":"30","author":"H Zhao","year":"2014","unstructured":"Zhao, H. et al. CrossMap: a versatile tool for coordinate conversion between genome assemblies. Bioinformatics 30, 1006\u20131007 (2014).","journal-title":"Bioinformatics"},{"key":"77187_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin, J. P., Triche, T. J. Jr. & Hansen, K. D. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics 33, 558\u2013560 (2017).","journal-title":"Bioinformatics"},{"key":"77187_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189\u2013196 (2013).","journal-title":"Bioinformatics"},{"key":"77187_CR60","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41592-018-0213-x","volume":"15","author":"SC Zheng","year":"2018","unstructured":"Zheng, S. C., Breeze, C. E., Beck, S. & Teschendorff, A. E. Identification of differentially methylated cell types in epigenome-wide association studies. Nat. Methods 15, 1059\u20131066 (2018).","journal-title":"Nat. Methods"},{"key":"77187_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-022-01285-7","volume":"9","author":"X Yao","year":"2022","unstructured":"Yao, X. et al. Comprehensive microRNA-seq transcriptomic profiling across 11 organs, 4 ages, and 2 sexes of Fischer 344 rats. Sci. Data 9, 201 (2022).","journal-title":"Sci. Data"},{"key":"77187_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03047-z","volume":"24","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Correcting batch effects in large-scale multiomics studies using a reference-material-based ratio method. Genome Biol. 24, 201 (2023).","journal-title":"Genome Biol."},{"key":"77187_CR63","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41587-023-01867-9","volume":"42","author":"Y Yu","year":"2024","unstructured":"Yu, Y. et al. Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profiling. Nat. Biotechnol. 42, 1118\u20131132 (2024).","journal-title":"Nat. Biotechnol."},{"key":"77187_CR64","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos, I. S. et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 43, W460\u2013W466 (2015).","journal-title":"Nucleic Acids Res."},{"key":"77187_CR65","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41587-023-01934-1","volume":"42","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Multi-omics data integration using ratio-based quantitative profiling with Quartet reference materials. Nat. Biotechnol. 42, 1133\u20131149 (2024).","journal-title":"Nat. Biotechnol."},{"key":"77187_CR66","unstructured":"Sjostedt, E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020)."},{"key":"77187_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77187-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:00:45Z","timestamp":1790636445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77187-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77187"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77187-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.P. and X.L. are employees and stockholders of Shenzhen Chipscreen Biosciences Co. Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10311"}}